Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antimalarial drugs.

Jochen Wiesner1, Regina Ortmann, Hassan Jomaa

  • 1Biochemisches Institut der Justus-Liebig-Universität, Friedrichstrasse 24, 35 392 Giessen, Germany. Jochen.Wiesner@biochemie.med.uni-giessen.de

Angewandte Chemie (International Ed. in English)
|November 13, 2003
PubMed
Summary

Malaria drug resistance is rising, threatening millions globally. Renewed research using parasite genomics and modern drug design offers hope for new antimalarial treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-coupling of aryl aldehydes and benzyl chlorides enabled by dual N-heterocyclic carbene/cobalt catalysis.

Chemical communications (Cambridge, England)·2026
Same author

Investigation of Muscarinic Acetylcholine Receptor M<sub>3</sub> Activation in Atomistic Detail: A Chemist's Viewpoint.

ChemMedChem·2024
Same author

Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patients.

International journal of cancer·2024
Same author

In Vitro Activities of Dithiocarbamate Derivatives against <i>Echinococcus multilocularis</i> Metacestode Vesicles.

Tropical medicine and infectious disease·2023
Same author

Distortional effects of separate accounting and formula apportionment on factor allocation.

Journal of business economics·2023
Same author

Identification and characterisation of the tegument-expressed aldehyde dehydrogenase SmALDH_312 of Schistosoma mansoni, a target of disulfiram.

European journal of medicinal chemistry·2023

Area of Science:

  • * Infectious Diseases
  • * Parasitology
  • * Pharmacology

Background:

  • * Malaria affects 40% of the global population, causing millions of deaths annually.
  • * Rising parasite resistance to antimalarial drugs, particularly chloroquine, is a major public health concern.
  • * Neglect in antimalarial drug development since the 1970s has exacerbated the problem.

Purpose of the Study:

  • * To highlight the urgent need for novel antimalarial drug development.
  • * To underscore the potential of new research approaches in combating malaria.

Main Methods:

  • * Analysis of global malaria prevalence and drug resistance trends.
  • * Review of factors contributing to the decline in antimalarial drug research.
  • * Exploration of advancements in parasite genomics and modern drug design.

Related Experiment Videos

Main Results:

  • * Drug-resistant malaria parasites are spreading rapidly, increasing the global burden of the disease.
  • * Recent public funding has revitalized interest in developing new antimalarial therapies.
  • * Genomic data from Plasmodium falciparum and advanced drug design methods are promising.

Conclusions:

  • * The fight against malaria requires urgent development of new drugs due to widespread resistance.
  • * Genomic insights into Plasmodium falciparum and modern drug design offer a promising path forward.
  • * Continued investment and research are crucial to combatting this persistent global health threat.